What is Laboratory Corp. of America Holdings?
It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.
0JSY · Verdict
Limited reward · moderate risk
0JSY's standout is cash flow; growth and profitability weigh on the picture.
Based on 88% data coverage
0JSY · Verdict
9% free-cash-flow margin
Rev +5.6% CAGR · earnings -11.8%
6% net margin · 11% ROE
Below average
Model-based scoring. For information only — not financial advice.
It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. The company is listed on the LSE in UK, and a P/E ratio of 0.1x.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.